Life Sciences Innovation Fund
Ontariooc-innovation.ca
Overview
Ontario's Life Sciences Innovation Fund (LSIF) is an early-stage co-investment fund that supports companies in Life Sciences and Healthcare Technologies sectors related to human health. The fund is aimed at addressing the unique challenges faced by life sciences entrepreneurs moving innovative and capital-intensive investments from a conceptual stage through to commercialization. OCI co-invests with angel and other investors to help de-risk the opportunity, assisting start-ups in becoming investor and customer ready and allowing them to attract follow-on investment.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vessl Prosthetics | Jun 2025 | Grant | Co-investor |
| TMRW | Jul 2024 | Series D | Co-investor |
| TMRW Life Sciences | Jul 2024 | Series D | Co-investor |
| HDAX Therapeutics | Jul 2024 | Grant | Co-investor |
| TMRW | Jul 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.